康芝藥業(300086.SZ):目前解熱鎮痛系列及感冒系列產品產能產量充足,能夠滿足市場需求
格隆匯7月19日丨有投資者向康芝藥業(300086.SZ)提問,“7月4日和5日創下的17.18℃的聯合紀錄,自19世紀50年代有儀器記錄以來,過去7天是地球上最熱的7天。德國萊比錫大學KarstenHaustein説,地球上一次如此炎熱是在大約12萬年前的艾木間冰期。請問貴公司關於小兒中暑類藥物有哪些,產量如何,是否有擴產計劃。”
康芝藥業回覆稱,公司目前生產、銷售的產品涵蓋兒童及成人的解熱鎮痛系列(如布洛芬顆粒、小兒清解顆粒、退熱貼、尼美舒利分散片等)、感冒系列(如感冒清熱顆粒、柴黃清熱顆粒、銀胡感冒散、氨金黃敏顆粒)等產品。目前解熱鎮痛系列及感冒系列產品產能產量充足,能夠滿足市場需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.